CTLA4 and neoplasm: Besides PD-1, immune cells can express other inhibitory receptors such as CTLA-4, T-cell immunoglobulin 3 (TIM-3), ITIM domain protein (T-cell immunoglobulin and ITIM domain, TIGHT) (100) to mediate tumor immune resistance.